SHARE

Forus secures $160m to scale AI platform easing treatment access

Forus raised over $160m to expand its AI platform that links doctors, payers, pharmacies and biopharma to speed prescribed treatments. The system automates prior auth, financial aid and routing. The tech is used nationwide.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.